Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human RKIP ELISA Kit (AC3651)
Cat.#: ASET-2240
Specifications
Description Human RKIP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human RKIP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.029 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1169 Human CELSR2 ELISA Kit (AC2580) Quantitative inquiry ASET-2186 Human Calretinin ELISA Kit (AC3597) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry ASET-1349 Monkey Luteinizing Hormone ELISA Kit (AC2760) Quantitative inquiry ASET-2312 Human Pannexin 1 ELISA Kit (AC3723) Quantitative inquiry ASET-2326 Mouse SFRP1 ELISA Kit (AC3737) Quantitative inquiry ASET-1124 Human SOX3 ELISA Kit (AC2535) Quantitative inquiry ASET-2490 Human PSPN ELISA Kit (AC3901) Quantitative inquiry ASET-1910 Human C Peptide ELISA Kit (AC3321) Quantitative inquiry ASET-1848 Rat Notch2 ELISA Kit (AC3259) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket